Cardiol Therapeutics Inc. Cash Flows From Used In Financing Activities
Cardiol Therapeutics Inc. (CRDL) reported Cash Flows From Used In Financing Activities of CAD 15.54 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-03-31
| Period end | Cash Flows From Used In Financing Activities 12 month |
|---|---|
| 2025-12-31 | 15.54M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 18.84M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | -55.38K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | -53.93K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 93.44M CAD 20-F · filed 2024-04-01 |
| 2020-12-31 | 16.30M CAD 20-F · filed 2023-03-29 |